Top Industry Leaders in the Ophthalmoplegia Market
Latest Ophthalmoplegia Companies Updates:
InMode acquires Syneron Candela: This strategic move unites two major players in the aesthetics space, creating a powerhouse with a broader range of technologies and devices for various conditions, including ophthalmic disorders that can cause ophthalmoplegia.
Bausch + Lomb partners with Verily, a subsidiary of Alphabet, to develop AI-powered solutions for ophthalmic surgery: This collaboration aims to leverage Verily's expertise in machine learning and data analytics to improve surgical accuracy and efficiency for conditions like strabismus, a type of ophthalmoplegia
Zeiss introduces the CALLISTO Q femtosecond laser system: This new platform features advanced imaging and automation capabilities for more precise and predictable surgery, potentially benefiting patients with ophthalmoplegia caused by certain conditions.
Alcon receives FDA approval for its PanOptix Trifocal IOL: This innovative lens boasts improved visual acuity and depth of field in various lighting conditions, potentially offering benefits for patients with ophthalmoplegia who require corrective lenses.
List of Ophthalmoplegia Key companies in the market:
- Novartis AG (Switzerland)
- ZEISS International (Germany)
- Valeant Pharmaceuticals International, Inc. (US)
- Amritt, Inc. (US)
- Medline Industries, Inc. (US)
- ALLERGAN (Ireland)
- Johnson & Johnson (US)